West Pharmaceutical Services(NYSE:WST) Declares Dividend of $0.1200.

West Pharmaceutical Services (NYSE:WST) had declared a cash dividend of $0.1200 on Jul 5, 2016. The shares will quote ex-dividend on Jul 18, 2016 and the record date has been fixed for Jul 20, 2016. On Jul 5, 2016 share price, the yield comes out to be 0.6325%. The dividend payable date has been fixed on Aug 3, 2016.

West Pharmaceutical Services (WST) made into the market gainers list on Fridays trading session with the shares advancing 1.28% or 0.98 points. Due to strong positive momentum, the stock ended at $77.28, which is also near the day’s high of $77.8. The stock began the session at $76.75 and the volume stood at 2,58,713 shares. The 52-week high of the shares is $77.8 and the 52 week low is $52.79. The company has a current market capitalization of $5,647 M and it has 7,30,77,552 shares in outstanding.

West Pharmaceutical Services(WST) last announced its earnings results on Apr 28, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $362.10M. Analysts had an estimated revenue of $355.92M. Earnings per share were $0.53. Analysts had estimated an EPS of $0.51.

Several Insider Transactions has been reported to the SEC. On Jun 2, 2016, Daniel Malone (Vice President & Controller) sold 3,950 shares at $74.95 per share price.Also, On May 25, 2016, Thomas W Hofmann (director) sold 2,466 shares at $73.57 per share price.On Mar 2, 2016, Michael A Anderson (Vice President & Treasurer) sold 16,414 shares at $63.60 per share price, according to the Form-4 filing with the securities and exchange commission.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *